10.3% Dividend Opportunity Amid Inflation Reports
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 19 2026
0mins
Source: NASDAQ.COM
- Dividend Yield Analysis: The current market presents a 10.3% average dividend yield from two closed-end funds, one yielding 9.3% and the other 12%, with their discounts to NAV at historically low levels, indicating potential for future price rebounds as investor sentiment shifts.
- Inflation and Rate Expectations: Despite recent CPI and PPI figures hitting 3.8% and 6% respectively, market concerns over interest rates remain underappreciated, with expectations that rates will gradually decline as the war concludes and the new Fed chair implements policy changes, creating a favorable environment for dividend investments.
- Impact of AI: Research from Goldman Sachs indicates that AI is eliminating approximately 16,000 jobs monthly, contributing to a slowdown in wage growth to 3.6%, which is below inflation levels, thereby increasing downward pressure on inflation and presenting an opportunity for investors to secure high yields.
- Portfolio Construction: By investing in the DoubleLine Income Solutions Fund and the BlackRock Health Sciences Term Trust, investors can achieve a stable monthly cash flow, with projected annual income reaching $29,755, significantly enhancing financial security amid rising inflation pressures.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BMEZ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BMEZ
About BMEZ
BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, diversified financial services, health care technology, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Discount Management Program Launch: BlackRock's discount management programs, initiated on January 1, 2026, aim to address trading discounts through a transparent framework, expected to run until September 30, 2026, enhancing shareholder alignment.
- Mid-Year Progress Snapshot: As of June 30, 2026, most funds in the program were trading below the 10% average daily discount threshold, indicating market stability for these funds and avoiding triggering tender offers.
- Tender Offer Conditions: If a fund's common shares trade at an average daily discount exceeding 10% during the measurement period, it plans to conduct a tender offer to repurchase at least 5% of its outstanding shares at 98% of NAV, providing a potential liquidity mechanism.
- Ongoing Monitoring and Updates: BlackRock will continue to monitor each fund's discount to NAV through the measurement period and expects to announce terms and timing of any resulting tender offers for qualifying funds after the period ends.
See More
- Distribution Amounts Announced: BlackRock's various funds announced per share distributions for June 30, 2026, with BME leading at $0.2621 per share, indicating strong earnings potential that is likely to attract more investor interest.
- Managed Distribution Plan: All funds have adopted a managed distribution plan aimed at supporting stable monthly distributions, ensuring investors receive consistent cash flow, thereby enhancing investor confidence and market stability.
- Diverse Sources of Income: The distributions come from net income, short-term and long-term capital gains, and return of capital, with 57% of BCX's distribution sourced from return of capital, demonstrating flexibility and adaptability in income management.
- Annual Performance Expectations: By June 30, 2026, BME is expected to have total annual distributions of $1.5726, showcasing its competitiveness in the market, which may further enhance its net asset value and encourage long-term investor retention.
See More
- Distribution Frequency Change: BlackRock's closed-end funds have announced a shift from monthly to quarterly distributions to enhance visibility on future payouts, while still maintaining monthly distributions, a change aimed at boosting investor confidence and optimizing liquidity.
- Distribution Amount Overview: For instance, the BlackRock Municipal 2030 Target Term Trust (BTT) has a monthly distribution of $0.0464, while the BlackRock 2037 Municipal Target Term Trust (BMN) distributes $0.09375, with the stability of these amounts helping to attract income-seeking investors.
- Managed Distribution Plan: The BlackRock Capital Allocation Term Trust (BCAT) and BlackRock ESG Capital Allocation Term Trust (ECAT) have adopted a managed distribution plan ensuring a monthly distribution rate of 20% of each fund's 12-month rolling average net asset value, aimed at providing stable cash flow and enhancing investor trust.
- Tax Compliance Notification: All funds have sent distribution notices to shareholders in compliance with Section 19 of the Investment Company Act of 1940, ensuring transparency and adherence to tax reporting requirements, which helps maintain the company's reputation and mitigate potential legal risks.
See More
- Distribution Plan Implementation: BlackRock's various funds announced per-share distributions on May 29, 2026, including $0.0697 for BCX and $0.2621 for BME, demonstrating the company's ongoing commitment to stable income distribution aimed at bolstering investor confidence.
- Transparent Income Sources: The distribution sources for each fund include net income, short-term and long-term capital gains, and return of capital, with 80% of BCX's distribution coming from capital return, reflecting strategic adjustments in its income strategy to ensure continuous cash flow in the current market environment.
- Managed Distribution Plan: All funds have adopted a managed distribution plan to ensure stable monthly distributions, and if income is insufficient, they will maintain distribution levels through capital returns, a strategy that helps attract investors seeking stable income and enhances market competitiveness.
- Annual Performance Expectations: As of May 2026, the annual total returns and distribution rates of the funds show varying degrees of growth, with BGR achieving an annualized return rate of 21.99%, indicating significant success in its investment strategy within the resources and energy sectors, thereby enhancing long-term investor confidence.
See More
- Dividend Yield Analysis: The current market presents a 10.3% average dividend yield from two closed-end funds, one yielding 9.3% and the other 12%, with their discounts to NAV at historically low levels, indicating potential for future price rebounds as investor sentiment shifts.
- Inflation and Rate Expectations: Despite recent CPI and PPI figures hitting 3.8% and 6% respectively, market concerns over interest rates remain underappreciated, with expectations that rates will gradually decline as the war concludes and the new Fed chair implements policy changes, creating a favorable environment for dividend investments.
- Impact of AI: Research from Goldman Sachs indicates that AI is eliminating approximately 16,000 jobs monthly, contributing to a slowdown in wage growth to 3.6%, which is below inflation levels, thereby increasing downward pressure on inflation and presenting an opportunity for investors to secure high yields.
- Portfolio Construction: By investing in the DoubleLine Income Solutions Fund and the BlackRock Health Sciences Term Trust, investors can achieve a stable monthly cash flow, with projected annual income reaching $29,755, significantly enhancing financial security amid rising inflation pressures.
See More
- Distribution Amounts Announced: BlackRock's various funds announced per-share distributions for April 30, 2026, with BCX at $0.069700 and BME at $0.262100, indicating the company's ongoing ability to distribute earnings and enhancing investor confidence.
- Managed Distribution Plan: All funds have adopted a managed distribution plan to ensure stable monthly distributions, with BCAT and ECAT distributing based on 20% of their 12-month rolling average net asset value, aimed at attracting more investors and maintaining liquidity.
- Transparent Sources of Income: As of April 30, 2026, the sources of distributions for each fund include net income, short-term, and long-term capital gains, with 87% of BCX's distributions coming from return of capital, reflecting the robustness of its investment strategy.
- Annual Performance Data: As of March 31, 2026, BCX reported an average annual total return of 15.21%, showcasing its competitiveness in the market and further solidifying BlackRock's leadership position in investment management.
See More







